Effects of glucagon-like peptide-1 analogs on prolactin: a randomized, double-blind, placebo-controlled crossover trial
Cyrill Muller, Bettina Winzeler(University of Basel), Sophia Lengsfeld(University of Basel), Fabienne Baur(University Hospital of Basel), Laura Werlen(University Hospital of Basel), Leila Probst(University Hospital of Basel), Emara Yara, D. Vogt(University of Basel), Cemile Bathelt(University of Basel)
Cited by 1
Related Papers
Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials
|The Lancet Respiratory Medicine|2023|124
Effects of dulaglutide on alcohol consumption during smoking cessation
|JCI Insight|2023|75
Effects of the glucagon-like peptide-1 receptor agonist dulaglutide on sexuality in healthy men: a randomised, double-blind, placebo-controlled crossover study
|EBioMedicine|2024|17
Effects of Glucagon-Like Peptide-1 Analogs on Sexual Desire: A randomized, double-blind, placebo-controlled crossover trial
|Endocrine Abstracts|2023|2
THU122 Effects Of A GLP-1 Agonist On Consumption Of Alcohol In Patients Treated For Smoking Cessation
|Journal of the Endocrine Society|2023|1